header-logo header-logo

16 June 2017 / Jonathan Cohen
Issue: 7750 / Categories: Features , Procedure & practice
printer mail-detail

Norwich Pharmacal orders: still in vogue?

nlj_7750_cohen

Flexible & adaptable to many situations, the Norwich Pharmacal order remains as useful as ever, says Jonathan Cohen

  • Norwich Pharmacal orders for disclosure are granted against third parties innocently caught up in wrongdoing.
  • They have widespread application and have been further developed in case law.

A Norwich Pharmacal order may be an old remedy, but it still has modern application. Its use in the past three years alone demonstrates its continuing flexibility. Norwich Pharmacal orders are court orders to disclose information or documents, granted against third parties who have become mixed up in wrongdoing through no fault of their own. They date back to a 1974 House of Lords case concerning the Norwich Pharmaceutical Company, Norwich Pharmacal v Customs and Excise Commissioners [1974] AC 133, [1973] 2 All ER 943.

The case

Norwich Pharmacal was the victim of a patent infringement. It knew 30 consignments of the compound, Furazolidone, which was covered by its patent, had been imported into the UK without licence and therefore in breach of its patent. It did not, however, know who was doing the

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit LLP—Caroline Williams

Jurit LLP—Caroline Williams

Private wealth and tax team welcomes cross-border specialist as consultant

Freeths—Michelle Kirkland Elias

Freeths—Michelle Kirkland Elias

International hospitality and leisure specialist joins corporate team as partner

Flint Bishop—Deborah Niven

Flint Bishop—Deborah Niven

Firm appoints head of intellectual property to drive northern growth

NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
back-to-top-scroll